The global automated external defibrillator market size reached a value of USD 1567.4 million in 2022. The market is likely to grow at a rate of 8.8% in the forecast period of 2023-2031 to reach a market value of USD 3329.9 million by 2031. Increasing investments from market players and technological advancements are anticipated to be the market’s primary growth drivers.
Automated external defibrillator (AED) is a compact and life-saving device, intended to cure cardiac arrest patients. The consolidation of cardiopulmonary resuscitation and early defibrillation helps in saving lives of cardiac arrest patients. Automated external defibrillator system consists of accessories, like pad electrodes and a battery, which play an essential role in detecting and interpreting an electrocardiogram and, hence, delivering an electric shock.
Automated external defibrillator is of two types- public access AEDs and professional use AEDs. Public access defibrillator is generally used by people who have minimal training. These public AEDs are commonly found in airports, schools, community buildings, hospitals, governmental buildings, and other public places for emergencies. Professional use defibrillator is used by skilled professionals like emergency medical technicians and paramedics, who have received additional improvised explosive device training.
AEDs are also classified based on the type of automation, that is, fully automated defibrillator and semi-automated defibrillator. Fully automatic defibrillator investigates the heart’s pulses and commands to deliver a defibrillation shock without the operator’s interference. Semi-automated defibrillator requires user intervention to provide a defibrillation shock by pressing a button in case of an abnormal heart rhythm.
Automated external defibrillator operation requires proper follow-up steps to deliver the correct treatment. These devices work on the ANALYSE and SHOCK mechanisms. As the device is being adhered to the patient’s chest, the rhythm analysis is initiated, which roughly lasts for 5-15 seconds, depending on the type of defibrillator. The presence of visual or auditory alarms indicate the presence of ventricular fibrillation. After that, a series of electric shocks are given to the patient depending on the ventricular fibrillation. Then reanalysis of the victim’s rhythm is done to provide a total of three shocks. After this operation, signs of circulation are checked, and chest compressions and ventilations are provided until the next minute.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to the automated external defibrillator market research report, the market can be categorised into the following segments:
Market Breakup by Product
Market Breakup by Type
Market Breakup by End User
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Region
The increasing incidence of cardiovascular diseases, increasing number of key leaders, and advancements in AED technology are the key factors driving the development of the automated external defibrillator market. The contemporary defibrillator technologies have eliminated the need for separate pacemaker implantation in patients, and these advancements have positively impacted the market growth.
Another major factor contributing to the market expansion is the increase in the geriatric population, as the risk of cardiovascular diseases increases with age. According to World Health Organisation, 17.9 million people died from cardiovascular diseases in 2019 alone, accounting for 32% of deaths worldwide.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America accounts for more than 60% of the global automated external defibrillator market share. This is because of the cumulative result of enhanced healthcare infrastructure and rising cardiovascular diseases. Significant expenditure by the Government of the United States has been significantly contributing to the growth of the market.
An automated external defibrillator raises the cardiac arrest survival rate by 70%. Reports suggest that the communities with AED training programs see a 40% increase in cardiac arrest survival rates. These positive results provide the pharmaceutical and biotechnological companies with a brighter global automated external defibrillator market outlook.
Artificial intelligence is also utilised in automated external defibrillator systems for better advancements, thus creating opportunities for investors in the global automated external defibrillator market.
Moreover, with the continuous efforts of scientists and the new advancements in technology, evolved ADEs are being manufactured enabling the best and most accurate treatment in minimal time. Various trials and tests are done to analyse and monitor the programming and operation of devices to avoid challenges and shortcomings in the future. Several ongoing clinical trials are also significantly contributing to the market growth.
The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the automated external defibrillator market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product||
|Breakup by Type||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Automated External Defibrillator Market Overview
3.1 Global Automated External Defibrillator Market Historical Value (2016-2022)
3.2 Global Automated External Defibrillator Market Forecast Value (2023-2031)
4 Global Automated External Defibrillator Market Landscape
4.1 Global Automated External Defibrillator Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Automated External Defibrillator Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global Automated External Defibrillator Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Automated External Defibrillator Market Segmentation
6.1 Global Automated External Defibrillator Market by Product
6.1.1 Market Overview
6.1.2 Semi-Automated External Defibrillator
6.1.3 Fully Automated External Defibrillator
6.2 Global Automated External Defibrillator Market by Type
6.2.1 Market Overview
6.3 Global Automated External Defibrillator Market by End User
6.3.1 Market Overview
6.4 Global Automated External Defibrillator Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Automated External Defibrillator Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Automated External Defibrillator Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Automated External Defibrillator Market
9.1 Market Share by Country
10 Latin America Automated External Defibrillator Market
10.1 Market Share by Country
11 Middle East and Africa Automated External Defibrillator Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Asahi Kasei Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Stryker Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Nihon Kohden Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Koninklijke Philips NV
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Mediana Co. Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Physio-Control, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 BPL Medical Technologies
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Kestra Medical Technologies, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 ViVest Medical Technology Co., Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 ZOLL Medical Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
18 Global Automated External Defibrillator Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market for automated external defibrillator attained a value of USD 1567.4 million in 2022.
The market is likely to grow at a CAGR of 8.8% during the forecast period of 2023-2031 to attain a value of USD 3329.9 million by 2031.
Semi-automated external defibrillator and fully automated external automated external defibrillator are the two major products available in the market.
The types can be categorised into wearable and non-wearable defibrillator.
The end-users of the product include hospitals, clinics, and homecare, among others.
The major regional markets include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Increase in cardiovascular cases due to the sedentary lifestyle and expanding research and developmental activities contribute to the growth of the market.
The key players in the global market include Asahi Kasei Corporation, Stryker Corporation, Nihon Kohden Corporation, Koninklijke Philips NV, Mediana Co. Ltd., Physio-Control, Inc., BPL Medical Technologies, Kestra Medical Technologies, Inc., ViVest Medical Technology Co., Ltd., ZOLL Medical Corporation, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.